Paola Maria Cinque - Infectious Diseases

Author Information

Paola Maria Cinque is a notable researcher in the field of Infectious Diseases, affiliated with the Department of Infectious Diseases at San Raffaele Scientific Institute and San Raffaele Vita-Salute University, located in Milan, Italy. Her work primarily focuses on understanding and treating viral infections, particularly those affecting the nervous system, and has made significant contributions to the field through her research on HIV and other viral infections.

Research Contributions

Paola Maria Cinque has contributed extensively to the field of Infectious Diseases, with a particular focus on HIV and viral infections affecting the central nervous system. Her research has explored various aspects such as the pathogenesis and potential treatments of Progressive Multifocal Leukoencephalopathy (PML), HIV viral load in cerebrospinal fluid, and the immune responses associated with vaccinations. Furthermore, she has been involved in studies assessing the benefits of physical activity on individuals living with HIV and the immune response to COVID-19 vaccinations.

Aliases

Paola Maria Cinque is known by several aliases, including P. Cinque, Paola Cinque, and P Cinque. These variants of her name are used in different publications and academic references.

Publication and Citation Metrics

Metric	Value
Total Citation Count	13,064
H-index	58
Total Paper Count	237

Publications:

Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.

DOI: 10.1111/hiv.13268

Year: 2022

Outcome of Progressive Multifocal Leukoencephalopathy Treated by Interleukin‐7

DOI: 10.1002/ana.26307

Year: 2022

Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization

DOI: 10.1007/s10875-021-01190-5

Year: 2022

Successful JC virus-targeted T-cell therapy for progressive multifocal leukoencephalopathy in a lung transplant recipient

DOI: 10.1016/j.healun.2022.04.001

Year: 2022

Cerebrospinal Fluid viral load across the spectrum of untreated HIV-1 infection: a cross-sectional multi-center study.

DOI: 10.1093/cid/ciab943

Year: 2021

Anti-HIV antibodies are representative of the latent reservoir but do not correlate with viral control in people with long-lasting virological suppression undergoing analytical treatment interruption (APACHE study).

DOI: 10.1093/jac/dkab060

Year: 2021

Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19

DOI: 10.1038/s41598-021-89270-9

Year: 2021

Seasonal betacoronavirus antibodies expansion post BNT161b2 vaccination associates with reduced SARS-CoV-2 VoCs neutralization

DOI: 10.1101/2021.08.15.21262000

Year: 2021

Benefits of a 12 week physical activity programme on muscle and bone health in people living with HIV

DOI: 10.1002/jcsm.12824

Year: 2021

Progressive multifocal leukoencephalopathy: Insights on pathogenesis and potential treatments

DOI: 10.1016/j.jns.2021.117990

Year: 2021

What is the global impact of Flaviviridae infections?

Are There Any Concerns About Drug Resistance?

Can Flaviviridae infections be prevented?

What is Antimicrobial Resistance?

How Do Apicomplexan Parasites Infect Hosts?

What are Zoonoses?

Can West Nile Virus be Prevented?

What is Lyme Disease?

When is the DTaP Vaccine Administered?

Who is eligible for Dengvaxia?

Partnered Content Networks

Relevant Topics